證券(quan)時報e公(gong)(gong)司訊，海爾生物(688139)11月27日晚間公(gong)(gong)告(gao)，股(gu)東奇君投資(zi)計劃合計減(jian)持(chi)不超(chao)過(guo)公(gong)(gong)司總股(gu)本的(de)6%，其(qi)中，通(tong)(tong)過(guo)集(ji)中競價方式(shi)減(jian)持(chi)不超(chao)過(guo)634.14萬(wan)股(gu)，占(zhan)公(gong)(gong)司總股(gu)本的(de)比(bi)例不超(chao)過(guo)2%；計劃通(tong)(tong)過(guo)大宗交易方式(shi)減(jian)持(chi)不超(chao)過(guo)1268.29萬(wan)股(gu)，占(zhan)公(gong)(gong)司總股(gu)本的(de)比(bi)例不超(chao)過(guo)4%。